Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), LifeMD (LFMD) and Novo Nordisk (NVO)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zai Lab (ZLAB – Research Report), LifeMD (LFMD – Research Report) and Novo Nordisk (NVO – Research Report).
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Zai Lab (ZLAB)
Bank of America Securities analyst David Li maintained a Hold rating on Zai Lab today and set a price target of $38.20. The company's shares closed last Tuesday at $37.22, close to its 52-week high of $39.77.
Li has an average return of 17.5% when recommending Zai Lab. ;'>
According to TipRanks.com, Li is ranked #6632 out of 9628 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Zai Lab with a $53.04 average price target.
LifeMD (LFMD)
In a report released today, David Larsen from BTIG maintained a Buy rating on LifeMD, with a price target of $18.00. The company's shares closed last Tuesday at $13.58.
According to TipRanks.com, Larsen is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -10.1% and a 29.7% success rate. Larsen covers the Healthcare sector, focusing on stocks such as Definitive Healthcare Corp, P3 Health Partners, and Oncology Institute. ;'>
LifeMD has an analyst consensus of Strong Buy, with a price target consensus of $12.00.
Novo Nordisk (NVO)
TD Cowen analyst Michael Nedelcovych maintained a Buy rating on Novo Nordisk today and set a price target of $105.00. The company's shares closed last Tuesday at $74.34, close to its 52-week low of $69.18.
According to TipRanks.com, Nedelcovych is ranked 0 out of 5 stars with an average return of -12.6% and a 33.3% success rate. Nedelcovych covers the Healthcare sector, focusing on stocks such as Takeda Pharmaceutical Company, Bausch Health Companies, and Molecular Partners AG. ;'>
Novo Nordisk has an analyst consensus of Hold, with a price target consensus of $92.71.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
5 minutes ago
- Globe and Mail
3 Dividend Stocks to Double Up on Right Now
Buy, sell, or hold? That's the question investors must continually ask about each stock in their portfolio. The correct answer might be to sell if your original investing thesis has changed. In many cases, the best course of action is to simply stay the course. Sometimes, though, adding more to your position makes sense. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Every now and then, the smartest strategy is to back up the truck and load up on more shares. Here are three dividend stocks to double up on right now. 1. AbbVie If there were a dividend hall of fame, I think AbbVie (NYSE: ABBV) should be in it. The major drugmaker is a Dividend King with 53 consecutive years of dividend increases. Since spinning off from Abbott in 2013, AbbVie has more than quadrupled its dividend payout. Its forward dividend yield currently tops 3.5%. Why double up on AbbVie now? Its dividend is one reason. However, an even more compelling motivation is that the company's growth should accelerate nicely over the next few years. AbbVie continues to be somewhat weighed down by the early 2023 loss of exclusivity for its then-top-selling drug, Humira. But the more time passes, Humira will have less of a drag on growth. Meanwhile, sales for the company's two successors to Humira -- Rinvoq and Skyrizi -- are soaring. AbbVie's pipeline also features several potentially solid growth drivers. The main argument against investing more heavily in AbbVie stock now is probably the Trump administration's threats of tariffs on pharmaceutical imports to the U.S. and the implementation of a most-favored-nation drug pricing plan. I suspect, though, that these won't derail AbbVie's growth much, if at all, over the near term and will likely be non-issues in the long term. 2. Enterprise Products Partners Want especially juicy income? Take a look at Enterprise Products Partners (NYSE: EPD). This master limited partnership (MLP) offers a forward distribution yield of 6.96%. Here's more good news: Enterprise has increased its distribution for 26 consecutive years. Yes, this sky-high distribution is a key factor behind my including Enterprise Products Partners on the list of dividend stocks to double up on right now. The stock won't have to deliver much in the way of appreciation to generate a double-digit percentage total return. I expect this midstream energy stock will provide nice growth, though. The U.S. is experiencing an explosion in the number of data centers, largely due to the breakneck adoption of artificial intelligence (AI). Many of these data centers will be powered by natural gas. That's great news for Enterprise Products Partners. Domestic demand isn't the only growth driver for Enterprise Products Partners, either. As co-CEO Jim Teague said in the MLP's first-quarter earnings call, "The bottom line is the world needs U.S. oil, natural gas, and natural gas liquids to provide for their people and to grow their economies." He's right -- and much of those hydrocarbons will flow through Enterprise's pipelines. 3. Realty Income Realty Income (NYSE: O) is listed third among the dividend stocks to double up on now, but it's only because I've listed the stocks alphabetically. There's a lot to like about this real estate investment trust (REIT). For starters, Realty Income's forward dividend yield is 5.66%. The company distributes its dividend monthly. It has also increased its dividend for 30 consecutive years, with a total of 131 dividend hikes during that period. If that's not enough to impress you, consider that Realty Income has generated a positive total operational return every year since its initial public offering in 1994. The stock's average total return since then is roughly 11%. Realty Income's growth prospects look good, too. The REIT targets a total addressable market of $14 trillion. Around $8.5 trillion of that market is in Europe, where the company has only two major rivals. Should you invest $1,000 in AbbVie right now? Before you buy stock in AbbVie, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AbbVie wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor 's total average return is1,062% — a market-crushing outperformance compared to177%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 23, 2025
CBC
an hour ago
- CBC
Senate Republicans advance Trump's 'Big Beautiful Bill' after dramatic late-night vote
Social Sharing Senate Republicans voting in a dramatic late Saturday session narrowly cleared a key procedural step as they race to advance U.S. President Donald Trump's package of tax breaks, spending cuts and bolstered deportation funds by his Fourth of July deadline. The tally, 51-49, came after a tumultuous night with Vice-President JD Vance at the Capitol to break a potential tie. Tense scenes played out in the chamber as voting came to a standstill, dragging for more than three hours as holdout senators huddled for negotiations, and took private meetings off the floor. In the end, two Republicans opposed the motion to proceed, joining all Democrats. There's still a long weekend of work to come. Republicans are using their majorities in Congress to push aside Democratic opposition, but they have run into a series of political and policy setbacks. Not all GOP lawmakers are on board with proposals to reduce spending on Medicaid, food stamps and other programs as a way to help cover the cost of extending some $3.8 trillion in Trump tax breaks. "It's time to get this legislation across the finish line," said Senate Majority Leader John Thune. Ahead of roll call, the White House released a statement of administrative policy saying it "strongly supports passage" of the bill. Trump himself was at his golf course in Virginia on Saturday with GOP senators posting about the visit on social media. But by nightfall, Trump was lashing out against holdouts, threatening to campaign against one Republican, Sen. Thom Tillis of North Carolina, who had announced he could not support the bill because of grave Medicaid cuts that he worried would leave many without health care in his state. Tillis and Sen. Rand Paul of Kentucky voted against. Pressure was mounting from all sides — billionaire Elon Musk criticized the package as "utterly insane and destructive." WATCH | Bill broke up Trump-Musk bromance: Trump, Musk and the big, beautiful bromance breakup 19 days ago Duration 5:04 The 940-page One Big Beautiful Bill Act was released shortly before midnight Friday, and senators are expected to grind through all-night debate and amendments in the days ahead. If the Senate is able to pass it, the bill would go back to the House for a final round of votes before it could reach the White House. With the narrow Republican majorities in the House and Senate, leaders need almost every lawmaker on board. A new analysis from the nonpartisan Congressional Budget Office said the Senate bill would increase by 11.8 million the number of people without health insurance in 2034. Senate Democratic leader Chuck Schumer of New York said Republicans unveiled the bill "in the dead of night" and are rushing to finish the bill before the public fully knows what's in it. He immediately forced a full reading of the text late Saturday in the Senate, which would take hours. WATCH | Federal minister says Canada pushing for tariff removal: Canada 'pushing' for tariff removal, Anand says after Trump halts trade talks | Power & Politics 1 day ago Duration 14:58 Make-or-break moment for GOP The weekend session could be a make-or-break moment for Trump's party, which has invested much of its political capital on his signature domestic policy plan. Trump is pushing Congress to wrap it up and has admonished the "grandstanders" among GOP holdouts to fall in line. The legislation is an ambitious but complicated series of GOP priorities. At its core, it would make permanent many of the tax breaks from Trump's first term that would otherwise expire by year's end if Congress fails to act, resulting in a potential tax increase on Americans. The bill would add new breaks, including no taxes on tips, and commit $350 billion to national security, including for Trump's mass deportation agenda. But the cutbacks to Medicaid, food stamps and green energy investments are also causing dissent within GOP ranks. The Republicans are relying on the reductions to offset the lost tax revenues but some lawmakers say the cuts go too far, particularly for people receiving health care through Medicaid. Meanwhile, conservatives, worried about the nation's debt, are pushing for steeper cuts. Canada's digital services tax under fire Dubbed the "revenge tax," Section 899 of Trump's One Big Beautiful Bill Act calls for a new withholding tax to be imposed on investment income paid out by American companies to investors who live in countries the U.S. government considers to have unfair or discriminatory taxes. Canada's digital services tax (DST), which hits companies like Amazon, Google, Meta, Uber and Airbnb with a tax on revenue from Canadian users, is among the taxes the U.S. considers discriminatory. In the last few weeks and months, Trump has given a number of rationales for escalating the trade dispute between Canada and the United States. On Friday, he zeroed in on the DST. The DST affects mega companies that offer digital services — like online advertising or shopping — and earn more than $20 million in revenue from Canadian sources. Giant companies like Amazon, Apple, Airbnb, Google, Meta and Uber will be taxed three per cent on the money they make from Canadian users and customers. WATCH | The potential big, beautiful impact on Canadian wallets: What Trump's 'Big Beautiful Bill' means for Canadians' wallets 28 days ago Duration 4:49 U.S. President Donald Trump indicated that he would increase government spending and loosen some fiscal restraints with a new spending bill dubbed the "big beautiful bill" last week. Mark Ting, a partner with Foundation Wealth and On The Coast's personal finance columnist, says that markets have already responded positively to the bill. The levy has been in place since last year, but the first payments are due starting Monday. It's retroactive to 2022, so companies will end up with a $2-billion US bill due by the end of July. Revenue is one big benefit. The Parliamentary Budget Office estimated last year that the tax would bring in more than $7 billion over five years.
Globe and Mail
an hour ago
- Globe and Mail
Here's How You Can Build Up a $1 Million Portfolio Even if You Have $0 in Savings Right Now
It's never too late or too early to start investing in the stock market. Even if you don't know much about stocks, there are easy ways to gain exposure to a wide range of companies through a single investment. By doing so, you can keep your risk relatively low while also setting yourself up to achieve some significant gains over the long term. If you don't have any money saved up today, you can still build up a portfolio of more than $1 million in the long run. As long as you have more than 30 investing years left and can afford to set aside $350 per month, you can set up a strategy for creating a portfolio worth more than $1 million. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » When investing for the long haul, focus on growth stocks To maximize your gains over the years, you'll want to invest in growth stocks because they have the most upside in the long run. While it may seem challenging to track the best growth stocks, an easy way to accomplish this is by investing in an exchange-traded fund (ETF) that tracks them. The Invesco QQQ Trust (NASDAQ: QQQ) can be the ideal investment for this purpose. The Invesco ETF holds a portfolio of 100 stocks -- the largest non-financial stocks on the Nasdaq exchange. It will rebalance and adjust over time to ensure that its holdings are reflective of the most valuable stocks on the exchange. Some examples of the stocks you'll get access to through this ETF today are Apple, Netflix, and Tesla. The fund charges an expense ratio of 0.2%, which isn't terribly high, especially when you consider the impressive returns it has generated over the years; it has soundly outperformed the market. S&P 500 vs QQQ data by YCharts How many years will it take for your portfolio to reach $1 million? Investing $350 per month in the ETF can be a great way to slowly build up your position. At that rate, you would be investing about $4,200 per year. And if you can keep up that habit for the long haul, it can potentially make you a millionaire. Here's how your portfolio might increase in value over the years, at varying annual returns. The market has averaged a long-run return of 10% and in the table below, I've included that rate along with a scenario where the Invesco fund both does better and worse. Year 9% Growth 10% Growth 11% Growth 30 $645,566 $797,764 $990,580 31 $710,535 $885,735 $1,109,667 32 $781,599 $982,917 $1,242,536 33 $859,328 $1,090,276 $1,390,779 34 $944,350 $1,208,877 $1,556,177 35 $1,037,347 $1,339,897 $1,740,715 Calculations by author. If the fund averages a 10% return, it would take 33 years for your portfolio to be worth $1 million. This involves investing $350 per month throughout those years. If, however, the ETF's returns aren't that high and it averages a rate of 9% instead, it would take 35 years of regular monthly investing before your portfolio would reach $1 million. A lot hinges on that annual return. If it's lower than you expect it to be, then you can adjust by changing your expectations and planning to invest for longer, or by adding more money to your portfolio. This can be done by either increasing the amount of your monthly investment or by adding a large lump sum to boost your balance. The more money in your portfolio that's growing and benefiting from the effects of compounding, the quicker you can get to your goal of reaching $1 million. But even with no money in your portfolio today, you can still set yourself up on a path to build up a big nest egg by the time you retire. Should you invest $1,000 in Invesco QQQ Trust right now? Before you buy stock in Invesco QQQ Trust, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Invesco QQQ Trust wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor 's total average return is1,062% — a market-crushing outperformance compared to177%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 23, 2025
